Sequoia Capital Leads ~USD231m Series F for Chinese Healthtech Miaoshou Doctor
Source(s): AVCJ
Sequoia Capital led a CNY1.5b (~USD231m) Series F for Miaoshou Doctor, a China-based healthcare services platform, with participation from Springhill Fund, B Capital Group, Hel Ved Capital, Orbimed, INCE Capital and others. Read more